{"nct_id":"NCT01632241","title":"Efficacy and Safety of Belimumab in Black Race Patients With Systemic Lupus Erythematosus (SLE)","status":"COMPLETED","status_verified_date":"2021-08","start_date":"2013-02-19","start_date_type":"ACTUAL","primary_completion_date":"2018-06-18","primary_completion_date_type":"ACTUAL","completion_date":"2019-01-28","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["GSK"]}